Editorial: Subclassification of AUS/FLUS category for thyroid nodules: trials and evidence-based clinical management

被引:0
|
作者
Bayraktaroglu, Taner [1 ]
Barut, Figen [2 ]
cakmak, Gueldeniz Karadeniz [3 ]
机构
[1] Dept Internal Med, Divison Endocrinol & Metab, Zonguldak, Turkiye
[2] Fac Med, Dept Pathol, Zonguldak, Turkiye
[3] Zonguldak Bulent Ecevit Univ, Fac Med, Dept Gen Surg, Zonguldak, Turkiye
来源
关键词
Bethesda System for Reporting Thyroid Cytopathology; Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance; AUS/FLUS; Thyroid Nodules; Fine Needle Aspiration Cytology; ASSOCIATION GUIDELINES; BETHESDA SYSTEM; MOLECULAR MARKERS; CLASSIFIER; DIAGNOSIS; CYTOLOGY; CANCER;
D O I
10.3389/fendo.2023.1209776
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Malignancy Rate in Thyroid Nodules Classified as Bethesda Category III (AUS/FLUS)
    Ho, Allen S.
    Sarti, Evan E.
    Jain, Kunal S.
    Wang, Hangjun
    Nixon, Iain J.
    Shaha, Ashok R.
    Shah, Jatin P.
    Kraus, Dennis H.
    Ghossein, Ronald
    Fish, Stephanie A.
    Wong, Richard J.
    Lin, Oscar
    Morris, Luc G. T.
    [J]. THYROID, 2014, 24 (05) : 832 - 839
  • [2] Patient outcomes following surgical management of thyroid nodules classified as Bethesda category III (AUS/FLUS)
    Mulita, Francesk
    Plachouri, Maria-Kerasia
    Liolis, Elias
    Vailas, Michail
    Panagopoulos, Konstantinos
    Maroulis, Ioannis
    [J]. ENDOKRYNOLOGIA POLSKA, 2021, 72 (02) : 143 - 144
  • [3] Importance of cytological subclassification of thyroid nodules with Bethesda category III cytology (AUS/FLUS) into architectural atypia only and nuclear atypia: A prospective study
    Rosario, Pedro Weslley
    Calsolari, Maria Regina
    [J]. DIAGNOSTIC CYTOPATHOLOGY, 2017, 45 (07) : 604 - 607
  • [4] Malignancy Rate in Thyroid Nodules Classified as Bethesda Category III (AUS/FLUS): Is There a Correct Answer?
    Heller, Keith S.
    [J]. THYROID, 2014, 24 (05) : 787 - 788
  • [5] Subclassification of atypia or follicular lesion of undetermined significance (AUS/FLUS) category of the Bethesda system for reporting thyroid cytopathology
    Song, D. -E.
    Roh, J.
    Baek, J. -H.
    Hong, S. -J.
    Kim, W. -B.
    Shong, Y. -K.
    [J]. VIRCHOWS ARCHIV, 2014, 465 : S244 - S244
  • [6] Management of thyroid nodules: a clinicopathological, evidence-based approach
    Furio Pacini
    Luca Burroni
    Cristina Ciuoli
    Giovanni Di Cairano
    Elisa Guarino
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2004, 31 : 1443 - 1449
  • [7] Management of thyroid nodules: a clinicopathological, evidence-based approach
    Pacini, F
    Burroni, L
    Ciuoli, C
    Di Cairano, G
    Guarino, E
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (10) : 1443 - 1449
  • [8] THE CONTRIBUTION OF CLINICAL AND RADIOLOGICAL FEATURES TO THE DIAGNOSIS IN AUS/FLUS AND FN/SFN THYROID NODULES
    Dogan, Lutfi
    Gulcelik, Mehmet Ali
    Karaman, Niyazi
    Baskan, Emel
    Kahraman, Yavuz Selim
    Aksel, Bulent
    Ozaslan, Cihangir
    [J]. ACTA MEDICA MEDITERRANEA, 2016, 32 (01): : 151 - 155
  • [9] Risk Stratification of Thyroid Nodules in Bethesda System Category III Cytopathology (AUS/FLUS) Using Subclassification and Gene Expression Classifier (GEC): A Single Aspirator's Experience
    Xu, Wei
    Sidawy, Mary K.
    Busseniers, Anne
    [J]. LABORATORY INVESTIGATION, 2018, 98 : 184 - 184
  • [10] Risk Stratification of Thyroid Nodules in Bethesda System Category III Cytopathology (AUS/FLUS) Using Subclassification and Gene Expression Classifier (GEC): A Single Aspirator's Experience
    Xu, Wei
    Sidawy, Mary K.
    Busseniers, Anne
    [J]. MODERN PATHOLOGY, 2018, 31 : 184 - 184